BiotechTube
Home/Pipeline/Percept™ PC with BrainSense™ for Epilepsy

Percept™ PC with BrainSense™ for Epilepsy

Epilepsy

Clinical InvestigationActive StudyNCT03946618

Key Facts

Indication
Epilepsy
Phase
Clinical Investigation
Status
Active Study
Company
Medtronic

About Medtronic

Medtronic is a pioneering medical technology company founded in 1949, best known for inventing the first wearable cardiac pacemaker. Its mission to 'alleviate pain, restore health, and extend life' is executed through a diversified portfolio of devices, therapies, and digital solutions across four core operating segments. The company's strategy combines deep clinical expertise, a people-centered approach, and strategic M&A to drive innovation in chronic disease management and personalized care.

View full company profile

Therapeutic Areas

CardiovascularNeuroscienceMedical SurgicalDiabetes

Other Epilepsy Drugs

DrugCompanyPhase
ADX71149 (mGlu2 PAM)Addex TherapeuticsPhase 2
TRV045TrevenaPhase 1
SAGE-324Sage TherapeuticsPreclinical
Motpoly XR™Aucta PharmaceuticalsNot Specified (Likely Phase 3/NDA)
ADB-104Adolore BioTherapeuticsPre-clinical
Not Publicly DisclosedCerecinPhase 2
eTNS PlatformNeuroSigmaUnknown
NPT 2042NeuroPro TherapeuticsPhase 2
Spritam (levetiracetam)Aprecia PharmaceuticalsApproved
PerampanelArk DiagnosticsIn Development
NeuroAccess PlatformCordance MedicalPre-clinical/Research
Epilepsy ProgramCurrent SurgicalResearch